Approximately 9 weeks after the initial detection of palpable tumours for both mice, PyMT-Fib-cKO mice developed markedly fewer and smaller metastatic lung nodules compared with PyMT-Fib-WT mice (Fig. 2h, i). This evidence concerns the gene FBL and neoplasm.